Sonoma Pharmaceuticals, Inc. (SNOA)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
29 Hits (67.44% Hit Rate)
FV Avg. Distance
+13.1%
About
CEO
Amy M. Trombly
Employees
254
Industry
-
Sector
-
Headquarters
Petaluma
Exchange
NASDAQ
Website
http://www.sonomapharma.comSummary Stats
Market Cap
5.05M
Revenue
-
Net Income
-
EPS
$0.00
Price-to-Earnings
-
Price-to-Book
-
Debt-to-Equity
-
News
Analyst Ratings
Price targets projected by 1 analyst
High
$9.00
Average
$9.00
Low
$9.00
Ratings calculated by 0 analysts
Buy
0
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q2 2023
Not Available
-$0.33 -
-
-0.04
Down 725%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--